InvestorsHub Logo
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Re: None

Thursday, 01/12/2017 7:43:14 AM

Thursday, January 12, 2017 7:43:14 AM

Post# of 20689
Momenta price target raised to $19 from $14 at Leerink

Leerink analyst Jason Gerberry raised his price target for Momenta (MNTA) to $19 from $14 based on an increased probability Momenta/Novartis (NVS) will launch a Copaxone 40mg generic by mid-2017. The analyst reiterates an Outperform rating on Momenta's shares. :theflyonthewall.com